• Two-Layer Screen Locates Both Drugs and Targets

    Dec 23, 2013, 12:35 PM by Michael Croft
    eScience News | Scripps researchers used a novel screening method to find a promising diabetes drug, and plan to expand the program to new disease areas.
    Full story
  • Cell Mechanics Gets a Powerful New Tool

    Dec 20, 2013, 11:35 AM by Michael Croft
    Bio-IT World | Researchers at Harvard’s Wyss Institute have developed the first method to measure the forces exerted by cells in living tissue – using decoy cells and some cunning computer imaging.
    Full story
  • Lifespan of Data Measured in Dog Years

    Dec 19, 2013, 11:20 AM by Michael Croft
    Cell Press | A paper by a team of Canadian researchers suggests that scientific data rarely survives as long as twenty years after publication.
    Full story
  • Crunch Time for the Arvados Project

    Dec 18, 2013, 13:25 PM by Michael Croft
    Bio-IT World | With $1.5 million in new venture financing, Curoverse is hoping to make the open source Arvados platform a serious commercial player in cloud-based bioinformatics.
    Full story
  • Fragile Expedition

    Dec 18, 2013, 09:55 AM by Michael Croft
    Bio-IT World | Following his 2012 success sequencing the evasive fragile X locus, Dr. Paul Hagerman wants to make a full clinical diagnostic, and an affordable screening test, available for fragile X disorder. He thinks he’s close.
    Full story
  • Personalized Cancer Care Makes IBM's 5 in 5

    Dec 17, 2013, 14:40 PM by Michael Croft
    VentureBeat | Every year since 2006, IBM has released its "5 in 5" list of new technologies that will change our daily lives within five years.
    Full story
  • New Horizons of Gene Editing

    Dec 17, 2013, 13:45 PM by Michael Croft
    Business Weekly | Horizon Discovery is expanding its Genesis gene editing platform to take advantage of Crispr, the revolutionary gene deletion technique developed last year.
    Full story
  • R Update for Hadoop

    Dec 16, 2013, 13:00 PM by Michael Croft
    Computerworld | A new version of R to be released today will run with the Hadoop data processing platform.
    Full story
  • Data Sharing and Training Rise to the Top in Lisbon

    Dec 13, 2013, 08:00 AM by Michael Croft
    Bio-IT World | Lisbon welcomed attendees to the 2013 Clinical Genomics & Informatics event last week with blue skies, plenty of pasteis de nata, and excellent discourse in clinical exome sequencing, high-scale computing, RNA sequencing, and genome informatics.
    Full story
  • Bigger, Faster and Crispr

    Dec 12, 2013, 13:55 PM by Michael Croft
    MIT News | Using the recently-developed Crispr system, researchers for the first time can perform genome-wide empirical studies of human cells, knocking down every known gene one by one.
    Full story
  • Decontaminating Sequencing Samples

    Dec 12, 2013, 08:25 AM by Michael Croft
    Bio-IT World News Brief | Appistry introduces a new tool to the Cancer Genome Analysis Suite, co-developed with the Broad Institute, which will mathematically filter out cross-contamination between tumor and normal samples.
    Full story
  • AllSeq's Knowledge Hub for the Next Generation of Sequencing

    Dec 12, 2013, 07:00 AM by Michael Croft
    Bio-IT World | AllSeq offers what it believes is a unique solution to the challenges in the age of commoditized sequencing. In a transparent way, the company matches researchers with sequencing centers, but also strives to be a knowledge base for all things sequencing. CSO Shawn Baker explains.
    Full story
  • Phil Bourne Named to New NIH Data Science Post

    Dec 11, 2013, 10:50 AM by Michael Croft
    Bio-IT World News Brief | Francis Collins, Director of the National Institutes of Health, has named Philip Bourne as the NIH’s first Associate Director for Data Science, to identify opportunities across the scope of the NIH’s activities to advance the use of big data in scientific discovery.
    Full story
  • Oracle Joins OpenStack's List of Sponsors

    Dec 11, 2013, 08:40 AM by Michael Croft
    Computerworld | Oracle has become a corporate sponsor of the OpenStack Foundation, joining such companies as Red Hat and IBM in support of the open source cloud operating system community.
    Full story
  • FoundationOne Heme Released for Clinical Use

    Dec 10, 2013, 10:20 AM by Michael Croft
    Business Wire | Foundation Medicine has released its second genetic cancer profiler for clinical use, this time targeting hematologic cancers and certain sarcomas.
    Full story
  • IBM Developing Cloud-Switching Software

    Dec 9, 2013, 15:00 PM by Michael Croft
    Computerworld | IBM is developing a software to let users switch between cloud services interchangeably. The software-- InterCloud Storage (ICStore)--is still in development, but customers are invited to test it.
    Full story
  • Strand Life Sciences Launches San Francisco Genomics Center

    Dec 9, 2013, 14:00 PM by Michael Croft
    Business Standard | Strand Life Sciences and El Camino Hospital in San Francisco are joining to set up a center for genomics and personalized medicine.
    Full story
  • The New Cancer Models, Part 3: The Cell Line Critics

    Dec 9, 2013, 07:00 AM by Michael Croft
    Bio-IT World | Researchers around the world are trying to improve on our laboratory cancer models to better reflect the variable genetic makeup of cancer. In Part 2, we look at the sorry state of cancer cell lines – and a team at Sloan-Kettering who want to improve it.
    Full story
  • 23andMe Suspends Sale of Health Tests

    Dec 6, 2013, 09:10 AM by Michael Croft
    Bio-IT World | After two contentious weeks of FDA pressure, the last personal genetic testing company to offer health information has at last caved to the regulatory agency's directives, suspending sale of the health-related reports associated with its Personal Genome Service kits.
    Full story
  • Myriad Still Holding Fast on BRCA Patents

    Dec 5, 2013, 15:15 PM by Michael Croft
    Bio-IT World News Brief | Myriad Genetics has launched a new lawsuit over its ownership of genetic tests for BRCA mutations, this time against Laboratory Corporation of America.
    Full story